# Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction

> **NCT03318874** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 70 (actual)

## Conditions studied

- Dry Eye Syndromes
- Meibomian Gland Dysfunction

## Interventions

- **DEVICE:** Blephasteam
- **DEVICE:** THERA°PEARL Eye Mask
- **DRUG:** Hylo-comod

## Key facts

- **NCT ID:** NCT03318874
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-19
- **Primary completion:** 2020-04-15
- **Final completion:** 2021-11-17
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-11-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03318874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03318874, "Optimization of the Treatment of Dry Eye Disease Caused by Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03318874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*